PTrana Meditama Metropolitan Tbk (ISX:SAME) Marketable Securities: Rp0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:SAME PT Sarana Meditama Metropolitan Tbk ISX:SAME
65 GF Score
Price Rp320.00
GF Value Rp354.65
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PTrana Meditama Metropolitan Tbk Marketable Securities?

PTrana Meditama Metropolitan Tbk ISX:SAME +3.90% 65 Marketable Securities is Rp0 Mil as of Jun. 2026. GuruFocus rates ISX:SAME with a GF Score™ of 65/100 and a GF Value™ of Rp354.65 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. PTrana Meditama Metropolitan Tbk's Marketable Securities for the quarter that ended in Jun. 2026 was Rp0 Mil.

PTrana Meditama Metropolitan Tbk's annual Marketable Securities declined from Dec. 2023 (Rp21,500 Mil) to Dec. 2024 (Rp4,500 Mil) and declined from Dec. 2024 (Rp4,500 Mil) to Dec. 2025 (Rp0 Mil).

PTrana Meditama Metropolitan Tbk  (ISX:SAME) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

PTrana Meditama Metropolitan Tbk Marketable Securities Related Terms

PTrana Meditama Metropolitan Tbk Marketable Securities Historical Data

* Premium members only.

The historical data trend for PTrana Meditama Metropolitan Tbk's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PTrana Meditama Metropolitan Tbk Marketable Securities Chart

PTrana Meditama Metropolitan Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 110,000.00 12,000.00 21,500.00 4,500.00 0.00

PTrana Meditama Metropolitan Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ISX:SAME
65GF Score
PT Sarana Meditama Metropolitan Tbk ISX:SAME
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PTrana Meditama Metropolitan Tbk Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of Rp0 Mil mean?
PTrana Meditama Metropolitan Tbk (ISX:SAME) has a Marketable Securities of Rp0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PTrana Meditama Metropolitan Tbk and its competitors.
Is PTrana Meditama Metropolitan Tbk's Marketable Securities too high?
PTrana Meditama Metropolitan Tbk's current Marketable Securities is Rp0 Mil. Overall, PTrana Meditama Metropolitan Tbk has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PTrana Meditama Metropolitan Tbk's Marketable Securities compare to HCA and THC?
PTrana Meditama Metropolitan Tbk's Marketable Securities of Rp0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PTrana Meditama Metropolitan Tbk and its competitors. PTrana Meditama Metropolitan Tbk's current Marketable Securities is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PTrana Meditama Metropolitan Tbk stock overvalued right now?
Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk (ISX:SAME) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp354.65, compared to a current price of Rp320.00 — trading 9.8% below its estimated fair value. The current Marketable Securities is Rp0 Mil. PTrana Meditama Metropolitan Tbk's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For PTrana Meditama Metropolitan Tbk (ISX:SAME), the current Marketable Securities is Rp0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PTrana Meditama Metropolitan Tbk (ISX:SAME) Overvalued in 2026?

Based on GuruFocus' analysis, PTrana Meditama Metropolitan Tbk stock appears to be undervalued. The current stock price of Rp320.00 is trading 9.8% below its estimated GF Value™ of Rp354.65. GuruFocus considers PTrana Meditama Metropolitan Tbk to be Modestly Undervalued.

Key valuation signals for ISX:SAME:

  • Marketable Securities: Rp0 Mil
  • GF Value™: Rp354.65 vs. price of Rp320.00 (9.8% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the ISX:SAME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PTrana Meditama Metropolitan Tbk Business Description

Address Jalan Pulomas Barat VI No. 20, RS EMC Pulomas, Kayu Putih, Pulogadung, Jakarta Timur, Jakarta, IDN, 13210
PT Sarana Meditama Metropolitan Tbk is engaged in managing hospitals. Its hospitals are operated under the brand name Omni Hospital. The company manages and evaluates its business based on its geographic location consisting of Omni Pulomas, Omni Alam Sutera, Omni Cikarang, OMNI Pekayon, and others. It operates in Banten, DKI Jakarta, and West Java.
65GF Score

Get the complete analysis for ISX:SAME

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp320.00
Price
Rp354.65
GF Value